CharlesBPorterMDFACC, FAHA, FICOS
Cardiology • Kansas City, KSProfessor, Cardiovascular Disease, University Kansas School of Medicine
Dr. Porter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
University of Kansas Med Center
4000 Cambridge MS 1023
Kansas City, KS 66160Phone+1 913-588-9697Fax+1 913-588-9450
Summary
- I founded the CardioOncology Program at the University of Kansas Medical Center in 2007. My primary commitment is to the KUMC Cardiooncology program’s advancement of patient care, research, education and training. I have continuous experience in heart failure since helping found the first cardiac transplant program in Kansas City Mo in 1985.
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Cardiovascular Disease, 1980 - 1983
University of Kansas School of MedicineResidency, Internal Medicine, 1977 - 1980- University of Kansas School of MedicineClass of 1977
Certifications & Licensure
MO State Medical License 1982 - 2026
KS State Medical License 1978 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Top MD Consumers Checkbook
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Dynamic Thoracic Impedance as a Marker for Heart Failure Decompensation Start of enrollment: 2014 Apr 01
Publications & Presentations
PubMed
- A novel outpatient regimen in management of fluoropyrimidine-induced cardiotoxicity.Anup Kasi, Pramod Gaudel, Manidhar Lekkala, Raed Al-Rajabi, Anwaar Saeed
Journal of Oncology Pharmacy Practice. 2023-12-01 - Immune-Checkpoint Inhibitor (ICI) resumption after severe graft injury in a heart transplant recipient with nivolumab-sensitive metastatic melanoma and renal cell carc...Warren Tai, Gary C Doolittle, Zubair Shah, James B Atkinson, Elaine Russell
The Journal of Heart and Lung Transplantation. 2022-12-01 - 24 citationsPermissive Cardiotoxicity: The Clinical Crucible of Cardio-Oncology.Charles Porter, Tariq U Azam, Divyanshu Mohananey, Rohit Kumar, Jian Chu
JACC. Cardiooncology. 2022-09-01
Press Mentions
Spotlight: Dr. Susan Lee, MDMay 22nd, 2024
Grant Support
- Cray Gift in Heart Failure and CardioOncologySally and Cloud Cray Jr Foundation2018–Present
Professional Memberships
- Fellow
- International Cardio-Oncology SocietyAmerican Vice President GCOS
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
